No Data
No Data
No Data
No Data
No Data
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2024...
PR NewswireApr 22 16:10 ET
Artivion's (NYSE:AORT) Investors Will Be Pleased With Their Notable 43% Return Over the Last Year
Yahoo FinanceApr 19 09:10 ET
Is Artivion (AORT) Outperforming Other Medical Stocks This Year?
Yahoo FinanceApr 15 09:40 ET
Needham Sees BSX, CNMD, RMD Beating Street, Despite Medtech Slow Down
Seeking AlphaApr 14 17:56 ET
Artivion Is Maintained at Buy by Needham
Artivion Is Maintained at Buy by Needham
Dow JonesApr 8 14:44 ET
Express News | Needham Maintains Buy on Artivion, Maintains $25 Price Target
Moomoo 24/7Apr 8 14:35 ET
No Data
No Data